Examine the US Pharmaceutical Industry's Political, Economic, Social and Technological...

Fri Mar 7, 2008 3:19pm EST

* Reuters is not responsible for the content in this press release.

Examine the US Pharmaceutical Industry's Political, Economic, Social and Technological Issues With This PEST Framework Analysis

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c85214) has announced the
addition of "US Pharmaceutical Industry - PEST Framework Analysis" to
their offering.

   Pharmaceutical is one of the most intense "Knowledge Driven"
industries, which is continually in a state of dynamic transition.
Diversities in life forms and diseases pose stiff challenge to the
design of specific and targeted solutions. The process of "drug
discovery/invention" is elaborate requiring on an average 8-10 years
at a cost of US$ 300 million to reach a new drug to the market.

   The US continues to generate the highest growth in the global
pharmaceutical industry, and analysts continue to witness robust sales
results in the country. An increasingly robust drug development
pipeline, ageing populations, and the ongoing demand for innovative
therapies are the driving forces behind this growth of the US
Pharmaceutical Industry.

   A PEST analysis is concerned with the environmental influences on
a business. The acronym stands for the Political, Economic, Social and
Technological issues that could affect the strategic development of a
business. Identifying PEST influences is a useful way of summarizing
the external environment in which a business operates.


   A. Executive Summary

   B. Introduction to the Industry

   B.1 Industry Definition

   B.2 Industry Profile

   B.3 Industry Structure

   B.4 Future Outlook

   C. PEST Framework Analysis

   C.1 Political Aspects

   C.2 Economic Aspects

   C.3 Social Aspects

   C.4 Technological Aspects

   D. Glossary of Terms

   For more information visit

Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980

Copyright Business Wire 2008